Winning HCP attention had become more difficult. Customer journeys were fragmented. Launch expectations were higher. Commercial teams had more channels, data and technology than ever, but not always clearer answers about where to focus. At the same time, every investment was under pressure to demonstrate value.
That was what the Future of Pharma Marketing & Sales Summit was built to address.
Over two days, attendees learned directly from the people doing the work. They examined successful launches and campaigns. They heard what HCPs actually wanted from pharma. They compared investment and channel decisions with their peers. They explored how leading teams were improving sales effectiveness, patient engagement, brand performance and commercial execution.
They left with new ideas, practical approaches and a stronger network to help them:
- Grow brands and increase adoption
- Earn greater HCP attention and engagement
- Make smarter marketing and channel investments
- Improve launch execution
- Strengthen field-force effectiveness
- Turn patient insight into commercial action
- Measure and demonstrate impact
- Apply AI and technology where they created genuine value
This wasn’t two days of theory about the future of pharma. It was two days focused on making better commercial decisions in the present.
























